MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2024-09-27 (mondaq.com)
VAT And Holding Companies: Review Of The Covidien Case
The judgment in the case of The Revenue Commissioners v Covidien Limited [2024] IEHC 192 was delivered on 11 April 2024 and upholds the earlier determination of the Tax Appeals Commission (TAC), 81TACD2022...
Read more2024-09-04 (elnuevodia.com)
The DDEC urges to approve legislation on the Global Minimum Tax in Puerto Rico
Manuel Cidre, secretary of the agency, reacted to the call made to the government by the CEO of Medtronic about the importance of implementing the global rate of 15%
Read more2024-04-12 (thecurrency.news)
Project Jameson and the “used-for test”: How Medtronic overturned a €45.9m tax bill
On Thursday, Mr Justice David Nolan delivered the High Court’s judgment in one of several tax battles opposing the multinational medical supplier Medtronic and the Revenue Commissioners. In this case, the judge re-examined a 2022 Tax Appeals Commission( TAC) determination made after poring over“ 32
Read more2024-01-09 (sharewise.com)
Why Medtronic Stock Got Off to a Roaring Start This Week
It isn't unusual for top medical device maker Medtronic (NYSE: MDT) to score regulatory approvals for its goods. Nevertheless, in the healthcare field, nearly any regulatory win is considered a
Read more2023-12-27 (marketbeat.com)
Czech National Bank Raises Stock Holdings in Medtronic plc (NYSE:MDT)
Czech National Bank lifted its holdings in shares of Medtronic plc (NYSE:MDT - Free Report) by 47.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 232,658 shares of the medical technology company's sto
Read more2023-12-18 (bloombergtax.com)
Tax Court Selected Unreliable Transfer-Pricing Method, IRS Says
The US Tax Court’s decision to reject the IRS’s method for pricing intercompany transactions by medical device-maker Medtronic Inc. violates Treasury regulations because it imposed too high a standard for comparing company profits, the agency said.
Read more2023-11-14 (yahoo.com)
Lattice Semiconductor Appoints John Forsyth and Que Thanh Dallara to Board of Directors
HILLSBORO, Ore., November 14, 2023--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced the appointment of Que Thanh Dallara and John Forsyth to the Company’s Board of Directors effective November 14, 2023. Mr. Forsyth will also serve as a member of the
Read more2023-09-22 (nst.com.my)
Anwar meets with Google, Boeing, Medtronic and Siemens Healthineers executives in New York
NEW YORK: Prime Minister Datuk Seri Anwar Ibrahim’s efforts to attract investors to Malaysia continued with separate meetings with four giant companies, namely Google, Boeing, Medtronic and Siemens Healthineers.
Read more2023-08-17 (natlawreview.com)
New Claim Construction in Patent Owner’s Post-Initiation IPR Response? Sure, Charge Away
Addressing the issue of new claim constructions presented by a patent owner after the institution of inter partes review (IPR) proceedings, the US Court of Appeals for the Federal Circuit fo
Read more2023-08-08 (informa.com)
Federal Circuit Court of Appeals Sides With Axonic Once More In Ongoing Patent Battle
A second decision from the Court of Appeals for the Federal Circuit rules that the PTAB’s pro-Medtronic decision in 2021 is invalid.
Read more2023-07-21 (natlawreview.com)
Hit a Nerve? Obviousness Inquiry Must Address Claims at Issue
The US Court of Appeals for the Federal Circuit vacated and remanded a Patent Trial & Appeal Board non-obviousness decision, finding that the context of the proposed combination of prior art in th
Read more2023-07-09 (mychesco.com)
FTC Takes a Stand: Challenging Antitrust Practices in the Medical Device Industry - MyChesCo
The Federal Trade Commission recently filed a friend-of-the-court (amicus) brief in the U.S. District Court for the Central District of California, clarifying legal standards that apply in antitrust cases involving exclusive-dealing and ...
Read more